ReviewTherapeutic innovation & regulatory science2026
Impact of Japanese Subpopulation Data and Overall Survival in Pivotal Trials on Oncology Drug Approvals in Japan.
Takanobu Watanabe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.